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Abstract
Background: The intestinal microbiome represents a complex network of microbes that are important for human health
and preventing pathogen invasion. Studies that examine differences in intestinal microbial communities across individuals
with and without enteric infections are useful for identifying microbes that support or impede intestinal health.
Results: 16S rRNA gene sequencing was conducted on stool DNA from patients with enteric infections (n = 200) and
75 healthy family members to identify differences in intestinal community composition. Stools from 13 patients were
also examined post-infection to better understand how intestinal communities recover. Patient communities had lower
species richness, evenness, and diversity versus uninfected communities, while principle coordinate analysis demonstrated
close clustering of uninfected communities, but not the patient communities, irrespective of age, gender, and race.
Differences in community composition between patients and family members were mostly due to variation in the
abundance of phyla Proteobacteria, Bacteroidetes, and Firmicutes. Patient communities had significantly more
Proteobacteria representing genus Escherichia relative to uninfected communities, which were dominated by
Bacteroides. Intestinal communities from patients with bloody diarrhea clustered together in the neighbor-joining
phylogeny, while communities from 13 patients’ post-infection had a significant increase in Bacteroidetes and
Firmicutes and clustered together with uninfected communities.
Conclusions: These data demonstrate that the intestinal communities in patients with enteric bacterial infections
get altered in similar ways. Furthermore, preventing an increase in Escherichia abundance may be an important
consideration for future prevention strategies.
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Background
In the US, diarrheal diseases are mostly caused by 31 dif-
ferent foodborne pathogens and were reported to contrib-
ute to 9.4 million infections, 55,961 hospitalizations, and
1351 deaths each year [1]. Among the bacterial infections
reported to FoodNet sites between 2000 and 2008, nonty-
phoidal Salmonella spp. predominated (11 %) followed by
Clostridium perfringens (10 %) and Campylobacter spp.
(9 %). Shiga toxin-producing Escherichia coli (STEC)
O157 and non-O157 also caused 0.7 and 0.6 % of infec-
tions, respectively, while Shigella spp. caused 1.4 % during
this same time frame [1]. In humans, these pathogens can
result in asymptomatic colonization, nonbloody diarrhea,
or hemorrhagic colitis [2], though they have also been
linked to more severe complications. STEC, for example,
can cause hemolytic uremic syndrome (HUS), which may
result in kidney failure and death, while C. jejuni can cause
neuropathies (e.g., Guillain Barré Syndrome) and paralysis
[3, 4] in a subset of patients. Although the virulence and
characteristics of a given pathogen influences disease
outcomes, the interaction between the pathogen and
host environment is also critical. Little is known, how-
ever, about how the microbiota impacts enteric disease
susceptibility, severity, and recovery.
Human intestinal communities were previously suggested
to comprise >1012 microbes/ml [5] with key functions
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including protection from pathogen proliferation, synthe-
sizing essential nutrients, metabolizing by-products, pro-
cessing indigestible products from the human diet, and
immunomodulation [6, 7]. Members of two phyla, the
Bacteroidetes and Firmicutes, have been found to dom-
inate in the intestines of healthy individuals, though
considerable variation has been observed [8]. Prior
studies have also demonstrated that intestinal commu-
nities are stable over time [9] and that several factors
including diet, lifestyle, age, probiotic and antibiotic
use, infection, and chronic conditions [10–12], can sig-
nificantly alter the diversity and abundance of the in-
testinal microbiota. In patients with inflammatory
bowel disease (IBD), for instance, a decrease in the
abundance of Bacteroidetes and Lachnospiraceae has
been observed [12], while bile acid profiles associated
with animal- versus plant-based diets were associated
with growth inhibition of Bacteroidetes and Firmicutes
[13]. Decreased abundance of members belonging to both
Bacteroidetes and Firmicutes was suggested to result in
enhanced susceptibility to enteric infections as it shifts the
microbial balance away from a healthy state. A prior study
in mice demonstrated that intestinal communities with a
high abundance of species closely related to pathogens were
more likely to be affected by those pathogens [14]. Com-
munities with a high abundance of commensal E. coli, for
example, were more susceptible to inflammation induced
by Salmonella enterica infections, whereas diverse intestinal
communities were more resistant to infection. Commensal
microbes were also suggested to alter pathogen virulence
gene expression profiles by modifying environmental condi-
tions [15]. These data underlie the importance of intes-
tinal communities in both promoting and inhibiting
pathogen proliferation; however, additional studies are
needed to identify which communities are most suscep-
tible to and protective against infection and how they
change with infection.
Several studies have also demonstrated that intestinal
communities are capable of recovering following pertur-
bations. In mice infected with Citrobacter rodentium, a
model for human enterohemorrhagic and enteropatho-
genic E. coli infections, alterations in the composition and
abundance of the intestinal microbiota could be restored
to a pre-infection state upon elimination of the pathogen
[16]. Similarly, restoration of intestinal communities dis-
rupted during antibiotic use has also been observed soon
after antibiotic cessation [17, 18].
Despite the recent interest and research on the intes-
tinal microbiome, few population-based human studies
have been conducted to better understand how the
microbiota is impacted by enteric pathogens with differ-
ent lifestyles. Here, we have compared the composition
and abundance of intestinal microbes between patients
with acute enteric infections and their uninfected family
members by 16S rRNA sequencing. We have also exam-
ined how the intestinal microbial communities from a
subset of patients change up to 14 weeks post-recovery,
and have identified specific microbial populations that
are correlated with clinical symptoms.
Results
Enteric disease cases identified via active surveillance are
representative of the Michigan population
As part of the Enteric Research Investigative Network
(ERIN) Cooperative Research Center (CRC) at Michigan
State University, we developed an active surveillance system
to identify patients with enteric infections at four participat-
ing hospitals and the Michigan Department of Health and
Human Services (MDHHS). To ensure that the ERIN sur-
veillance network is representative of statewide enteric in-
fection frequencies and that our results are generalizable,
we compared the frequency of all ERIN cases (n = 615)
identified between January 1, 2011 and May 7, 2014 to all
cases (n = 7435) identified throughout the State of
Michigan during the same time period. For each pathogen,
the frequency of cases was similar even after stratifying by
gender, though a difference was observed after stratifying
by age group (data not shown). Because the ERIN network
targeted hospitals with the largest pediatric populations, we
have captured more pediatric cases, particularly those in
the youngest age group.
A total of 310 stool samples were included for 16S
rRNA sequencing analysis. These stools originated from
200 patients infected with Campylobacter (n = 71),
Salmonella (n = 66), Shigella (n = 34), and STEC (n = 28);
the pathogen was not known for one patient. A total of 75
stools from otherwise healthy family members were also
included for comparison, with 64 (85 %) representing 22
families ranging in size between two and six participants.
Intestinal microbial communities are distinct between
patients with enteric disease and healthy family members
Rarefaction analysis revealed that communities were sam-
pled completely with between 60 to 120 OTUs per sample
and at 1000 sequences per sample (Fig. 1). The richness
and diversity of the intestinal communities of uninfected
individuals (Additional file 1: Table S1) was significantly
higher than the patient communities (Additional file 2:
Table S2) as estimated by the Chao1 and Shannon in-
dices. For example, Chao1 estimated the microbial
communities from all patients to comprise an average
of 109 compared to 173 OTUs for uninfected family
members. Community composition also differed sig-
nificantly between the uninfected family members and
patients by non-parametric multivariate analysis of
variance (NPMANOVA) based on both the Jaccard
similarity coefficient (P < 0.0001) and Bray-Curtis dissimi-
larity index (P < 0.0001). Moreover, principal coordinates
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analysis demonstrated tighter clustering of intestinal
communities from uninfected family members relative
to patient communities based on both the number and
abundance of OTUs (Additional file 3: Figure S1). Clus-
tering was not observed among patients infected with
different pathogens, though significant differences were
observed in the OTU composition and abundance across
patients using the NPMANOVA test. Campylobacter-
infected communities, for example, were significantly
different from Salmonella, STEC and Shigella commu-
nities in both composition (Jaccard similarity coefficient
P = 0.023, P = 0.003, and P = 0.0004) and abundance
(Bray-Curtis dissimilarity index P = 0.0003, P = 0.01, and
P = 0.014), respectively. Significant differences were
also observed using UniFrac weighted and unweighted
distances calculated by the analysis of similarities
(ANOSIM) and multivariate ANOVA based on dis-
similarities (ADONIS) methods (data not shown).
At the phylum level, a higher abundance of Bacteroidetes
and Firmicutes was observed in the uninfected family mem-
bers compared to the patients, whereas Proteobacteria was
more abundant in the patient communities (Fig. 2). Indeed,
Proteobacteria dominated and comprised >20 % of the in-
testinal community in 121 (61 %) cases; two patients in-
fected with Salmonella and STEC had communities
comprising 99 % Proteobacteria. A total of 28 OTUs repre-
senting phylum Proteobacteria were classified in the unin-
fected communities, though variation in OTUs was
observed in the communities infected with the four differ-
ent pathogens (range, 38 to 59 OTUs). Variation in the
Fig. 1 Differences in operational taxonomic units (OTUs) among individuals with and without enteric infections. Rarefaction curve representing
the number of OTUs by the number of sequences sampled in intestinal communities from patients with Shiga toxin-producing Escherichia coli
(STEC), Salmonella, Shigella, and Campylobacter infections relative to uninfected family members
Fig. 2 Phyla abundance in communities from a healthy family members and b patients with enteric infections. Only phyla that were shared
between the two groups are highlighted for comparison; bars represent averages within each phyla and black dots represent outliers
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abundance of Proteobacteria was also observed as 37 % of
patients with Campylobacter, 29 % with Salmonella, 18 %
with STEC, and 38 % with Shigella infections had over
50 % Proteobacteria. Among these infected communities,
Gammaproteobacteria represented more than 92 % of the
Proteobacteria detected (Additional file 3: Figure S2),
though some variation was observed. Patients infected with
Campylobacter, for example, had the highest level of Epsi-
lonproteobacteria, which likely represents an overabun-
dance of the pathogen in these cases relative to the others,
though Gammaproteobacteria still predominated.
To further demonstrate that the differences observed
across patients infected with the different pathogens
were not attributable solely to an increase in the abun-
dance of the actual pathogen, we also examined genera
abundance and composition across patients. Notably,
genus Escherichia predominated across communities re-
gardless of the pathogen causing the infection (Additional
file 3: Figure S3), though the highest levels were found in
STEC cases. The similarity percentages (SIMPER) analysis
demonstrated that Escherichia was responsible for the high-
est average dissimilarity (10.9) across the infected commu-
nities relative to the uninfected communities. The mean
abundance of Escherichia in communities infected with
Campylobacter, Salmonella, Shigella and STEC was 0.21,
0.14, 0.24, and 0.21, respectively, relative to uninfected
communities (0.01). More specifically, the population of
Gammaproteobacteria from Campylobacter cases repre-
sented 29 genera with Escherichia comprising 60 %
followed by Trabulsiella (7 %) and unclassified Pseudomo-
nadaceae (7 %). Genus Campylobacter was only detected
on average in 0.01 % of 41 of the 71 Campylobacter cases,
which represented 3.7 % of the total Proteobacteria levels.
Salmonella cases had 27 genera represented from Gamma-
proteobacteria with Escherichia and Trabulsiella predomin-
ating at 45 and 21 %, respectively, followed by Citrobacter
(12 %) and unclassified Enterobacteriaceae (10 %). Only 22
of the 66 Salmonella cases had detectable levels (average
0.002 %) of genus Salmonella, which represented 0.52 % of
the total Proteobacteria levels. For STEC cases, 21 genera
were identified with Escherichia comprising 77 % of the
Gammaproteobacteria population identified, which repre-
sented the total level of Proteobacteria detected in these
cases. A total of 23 genera were detected in Shigella
cases with most belonging to Escherichia (69 %), un-
classified Pseudomonadaceae (8 %), and Klebsiella
(6 %). Genus Shigella was not detected in any of the
cases, though unclassified Enterobacteriaceae was
found at an average of 0.007 %. None of the cases had
levels of unclassified Enterobacteriaceae exceeding 10 %.
Together, these data demonstrate that the distribution of
genera differed among the intestinal communities from pa-
tients, which was also indicated in the NPMANOVA ana-
lysis; however, Escherichia predominated in most infected
communities regardless of the pathogen causing the
infection.
Similar findings were observed utilizing the linear dis-
criminant analysis (LDA) effect size (LEfSe) method
[19], which identified 14 microbial features (LDA > 2.4)
to be differentially abundant in the patient communities
relative to uninfected communities (Additional file 3:
Figure S4). Among infected versus uninfected commu-
nities, the most abundant features at the family level
were Enterobacteriaceae followed by Pateurellaceae,
Lactobacillales, Streptococcaceae, and Lachnospiraceae.
At the genus level, Bacteroides dominated in 86.7 % of
the samples from healthy family members with a range
between 6 and 75 %, while Prevotella were found in
13.3 % with a range of 16 to 65 %. Among the intestinal
communities from healthy individuals, a total of 38 mi-
crobial features were differentially abundant. At the
family level, most of these features were classified as
Rikenellaceae, Bacteroidaceae, Ruminococcaceae, Por-
phyromonadaceae, Bifidobacteriaceae, Alcaligenaceae,
Odoribacteraceae, Barnesiellaceae, and Lachnospira-
ceae. The genera Roseburia, Lachnospira, and Blautia of
the Lachnospiraceae family were most abundant in healthy
family members compared to patients. Overall, no micro-
bial features were differentially abundant in the communi-
ties of patients infected with different pathogens.
Hierarchical clustering indicates that intestinal microbial
communities from patients with enteric infections are
similar
Microbial community composition was examined based
on the Bray-Curtis dissimilarity index to compare micro-
biota profiles between patients (infected communities)
and healthy family members (uninfected communities).
Five distinct clusters were identified with the infected
and uninfected communities separating into different
sections of the neighbor-joining tree (Fig. 3). Specifically,
77 % (n = 153) of the infected communities belonged to
clusters I or II, whereas 91 % (n = 68) of the uninfected
communities belonged to clusters III and IV. Based on
the placement within the dendrogram, communities of
cluster V, which originated from one uninfected individual
and five patients, were grouped together with communities
belonging to clusters III and IV for subsequent analyses.
Overall, intestinal communities from patients were signifi-
cantly more likely to group within clusters I or II, while
uninfected communities grouped within clusters III–V
(likelihood ratio chi-square (χ2) = 109.2; P = <0.0001).
At the phyla level, clusters I/II had significantly different
microbiota profiles in both the weighted and unweighted
analysis (NPMANOVA, P < 0.0001) when compared to
clusters III–V. A significantly higher average percentage of
phylum Proteobacteria (42 %) was observed in clusters I/II
relative to clusters III–V (6 %), while Bacteroidetes (38 %)
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and Firmicutes (17 %) were more common in the latter
three clusters. Among the uninfected communities belong-
ing to clusters III–V, the abundance of Bacteroidetes (59 %)
and Firmicutes (33 %) was even higher. Significant differ-
ences were also observed at the genus level. Intestinal com-
munities representing clusters I and II (n = 160) were
dominated by Escherichia, Trabulsiella, Citrobacter, unclas-
sified Pseudomonadaceae, or Bacteroides, whereas commu-
nities of clusters III–V (n = 115) were dominated by
Bacteroides or Prevotella. Notably, Escherichia was signifi-
cantly more abundant in communities belonging to clusters
I and II compared to communities of clusters III, IV, and
V as were Trabulsiella and unclassified Enterobacteriaceae
(P < 0.0001). Bacteroides, Parabacteroides, Faecalibacter-
ium, Roseburia, Ruminococcus, Suturella, and unclassified
Lachnospiraceae, however, were significantly more abun-
dant in clusters III–V (Additional file 3: Figure S5). Col-
lectively, these data highlight the differences in the
Fig. 3 Microbiota profiles among intestinal communities from patients with and without enteric infections. The dendrogram was constructed
using the Neighbor-joining method based on the Bray-Curtis dissimilarity index with 1000 bootstrap replications. Hierarchical clustering identified
five distinct groups (clusters I–V). Communities from healthy family members (Controls) are labeled in green outside the phylogeny, while patients
infected with Salmonella, Campylobacter, Shigella, and Shiga toxin-producing E. coli (STEC) are represented by different colors
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composition and abundance of intestinal microbes
across cluster groups and suggest that the microbiota
profiles are more similar among patients with enteric
infections. No differences in cluster classification were
observed across patients infected with different patho-
gens (Fig. 3).
Specific microbiota profiles are associated with
demographics and clinical symptoms
To determine whether differences in the intestinal micro-
biota profiles were associated with disease severity and
other patient characteristics, we evaluated epidemiological
data by the cluster groups defined in the Neighbor joining
phylogeny (Fig. 3). No significant associations were identi-
fied between the microbiota profiles and age or gender
among all individuals examined; however, after omitting
uninfected communities from the analysis, male patients
were significantly more likely to have profiles representing
clusters I/II than clusters III–V (Table 1). Children less than
18 years of age were also more likely to have cluster I/II in-
testinal microbiota profiles, but the association was not sta-
tistically significant. Importantly, several symptoms were
more frequently reported by patients with microbial com-
munities belonging to clusters I/II. Among the patients
who had reported vomiting or fever, for instance, 85 and
83 %, respectively, had intestinal communities belonging to
Table 1 Univariate analaysis highlighting the association between intestinal microbiota profiles and host factors among 200 patients
with enteric infections
Community clusters I and II (n = 152) Community clusters III–V (n = 47)
Characteristics No. (%) of individuals No. (%) of individuals P valuea
Age group 0.17
0–2 years (n = 31) 25 (16.5) 6 (12.8)
3–18 years (n = 55) 44 (29.0) 11 (23.4)
19–52 years (n = 76) 58 (38.2) 18 (38.3)
>52 years (n = 37) 25 (16.5) 12 (25.5)
Gender 0.02
Male (n = 104) 86 (57.3) 18 (38.3)
Female (n = 93) 64 (42.7) 29 (61.7)
Symptoms
No diarrhea (n = 3) 2 (1.5) 1 (2.3) 0.03
Diarrhea only (n = 91) 63 (46.3) 28 (65.1)
Bloody diarrhea (n = 85) 71 (52.2) 14 (32.6)
No vomiting (n = 118) 84 (62.7) 34 (79.1) 0.05
Vomiting (n = 59) 50 (37.3) 9 (20.9)
No fever (n = 62) 42 (33.9) 20 (54.1) 0.03
Fever (n = 99) 82 (66.1) 17 (46.0)
Length of hospitalization 0.67
None (n = 126) 94 (66.2) 32 (74.4)
1–2 days (n = 19) 18 (12.7) 1 (2.3)
≥3 days (n = 40) 30 (21.1) 10 (23.3)
Type of pathogen (n = 199) 0.05
Campylobacter (n = 71) 55 (36.2) 16 (34.0)
Salmonella (n = 66) 49 (32.2) 17 (36.2)
Shiga toxin E. coli (n = 28) 16 (10.5) 12 (25.5)
Shigella (n = 34) 32 (21.1) 2 (4.3)
Percentages represent the frequency of each characteristic out of the total number of patients per cluster group. Denominators for host characteristics do not
always add up to the total number of infected individuals (n = 200) as some data were missing. Symptom data was missing for up to 23 patients. Because most
patients with missing data had microbiota communities belonging to clusters I/II, it is not likely that inclusion of the missing data would impact the direction of
each significant association
aThe likelihood ratio chi-square or Mantel-Haenszel chi-square (for variables with more than two outcomes) were used to highlight differences between clusters I–II and
clusters III–V
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clusters I/II. A similar association was observed for bloody
diarrhea, which was reported by patients during the time of
their infection. Among 179 patients with data available, in-
dividuals reporting bloody diarrhea were twice as likely to
have cluster I/II intestinal communities compared to indi-
viduals reporting nonbloody diarrhea (P = 0.04). Indeed,
only 14 of the 85 patients (17 %) with bloody diarrhea had
intestinal communities belonging to clusters III–V. No as-
sociation was observed between specific intestinal micro-
biota profiles and length of hospitalization, patient age
group, or history of nausea, headache, fatigue, and chills.
While adjusting for age, gender, and intestinal micro-
biota profile, logistic regression analyses demonstrated
that patients with intestinal communities belonging to
clusters I/II were significantly more likely to have bloody
diarrhea (odds ratio (OR), 2.3; 95 % CI, 1.12, 4.82). Male
gender, however, resulted in a protective effect (OR, 0.5;
95 % CI, 0.28, 0.91), and no association was observed for
length of hospitalization. Addition of pathogen type to the
logistic regression model resulted in similar associations
for gender and cluster, but also showed that patients with
STEC infections were significantly more likely to have
bloody diarrhea when compared to patients with Salmon-
ella, Shigella, and Campylobacter (OR, 3.7; 95 % CI, 1.37,
9.79). Nonetheless, these data suggest that individuals with
more severe disease, as measured by the presence of
bloody diarrhea, were more likely to have intestinal com-
munities with similar profiles regardless of age and infec-
tion by three of the four pathogens.
The intestinal microbial communities of patients up to
14 weeks post-infection mimics the intestinal communities
of healthy family members
Stool samples from a subset of 13 patients at one to
14 weeks following recovery from Campylobacter (n = 3),
Salmonella (n = 6), and Shigella (n = 4) infections were ex-
amined to assess how intestinal communities changed fol-
lowing an enteric infection. In each case, a shift in the
intestinal community was observed following recovery. Col-
lectively, the recovered intestinal communities had greater
richness, evenness, and diversity relative to the communi-
ties that were present during the acute infection (Additional
file 3: Figure S6). Comparisons were also made between in-
fected intestinal communities, recovered communities, and
communities from healthy family members. Principle co-
ordinate analysis based on the Bray-Curtis dissimilarity
index demonstrated that recovered communities become
more similar to the healthy communities regardless of
the pathogen that originally caused the enteric infection
(Fig. 4). Notably, the phyla associated with the shift in
community composition post-recovery were Bacteroidetes,
Firmicutes, and Proteobacteria. At the time of the acute in-
fections, Bacteroidetes and Firmicutes were significantly less
abundant than in both the communities from recovered
patients and healthy family members (P < 0.0001), while the
level of Proteobacteria was significantly greater (P < 0.0001)
(Additional file 3: Figure S7). No significant difference was
observed in the abundance of Bacteroidetes and Firmicutes
in the recovered communities relative to communities from
healthy family members, though Proteobacteria abundance
was still significantly greater in recovered communities
post-infection (P = 0.025). Such differences are likely attrib-
utable to variation in the time that each recovered patient
was evaluated as patients submitted a follow-up sample
between 1 and 14 weeks post-infection. Indeed, Proteo-
bacteria levels decreased over time across the 14 week
follow-up period in all patients regardless of the pathogen
causing each infection. At the genus level, this decrease in
Proteobacteria was mostly attributable to a decrease in
Escherichia, which coincided with an increase in Bacter-
oides, Prevotella, Parabacteroides, and Rikenellaceae in
phylum Bacteroidetes and Faecalibacterium belonging to
phylum Firmicutes (Additional file 3: Figure S8).
Discussion
Although the microbial communities of the human gut
have been found to be both complex and diverse with
considerable variation across individuals [6, 8], our
examination of the intestinal microbiota from patients
with enteric infections has shown a decreased diversity
relative to intestinal communities from healthy individ-
uals. This finding is not surprising in that individuals
suffering from acute diarrhea can lose up to 200 g of
stool and fluids each day [20], thereby inducing a signifi-
cant change to the intestinal microbiome. Through this
study, however, we have demonstrated that patients with
acute enteric infections caused by four different bacterial
pathogens have similar deficiencies in the abundance of
certain intestinal microbes. It is therefore likely that spe-
cific microbial populations are more commonly selected
for during the course of an infection, and that restoring
intestinal health relies on the time it takes these intes-
tinal communities to recover and shift back to a pre-
infection or healthy state.
Irrespective of the bacterial pathogen that caused each
infection, a greater abundance of Proteobacteria and
lower abundance of Bacteroidetes and Firmicutes was
detected in the patients’ (infected) intestinal communi-
ties when compared to the uninfected communities of
healthy family members. Both Bacteroidetes and Firmi-
cutes have previously been associated with intestinal
health [8], and all patients in this study had significantly
lower levels of both phyla relative to uninfected family
members. In addition, among the 200 patients with en-
teric infections, 63.5 % of the population had communi-
ties comprising >20 % Proteobacteria compared to an
average of only 4.3 % of the healthy individuals (n = 75).
Although the total number and relative abundance of
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OTUs uncovered in the intestinal communities from
individuals were lower than in prior studies, all stool
samples were preserved in the same conditions with
Cary-Blair media, which had little effect on the presence
and abundance of specific community members following
experimental inoculation of cattle feces (Additional file 3:
Figure S9). Because each intestinal community was simi-
larly affected by the preservation media, differences could
be identified and comparisons could be made across indi-
viduals with and without disease. Likewise, given the chal-
lenges associated with DNA recovery from gram-positive
bacteria, it is possible that the abundance of specific com-
munity members may have been underestimated. Since the
same DNA isolation protocol, which incorporated a recom-
mended mechanical disruption step [21], was utilized for
each stool sample and high frequencies of gram-positive
bacteria were recovered from many samples, we do not ex-
pect that the differential recovery of these bacteria in the
uninfected versus infected samples contributed to bias in
this study. In addition, our results showing increased levels
of Proteobacteria in infected communities are similar to
those generated in prior studies and suggest that enhanced
Proteobacteria may be indicative of a diseased state that
commonly occurs during enteric infections or following
perturbations in the microbiota. One previous study, for ex-
ample, observed an overgrowth of Enterobacteriaceae after
C. rodentium infection in mice due to microbiota depletion
and induction of host inflammatory responses [16], while
patients with inflammatory bowel disease had increased
levels of Enterobacteriaceae [22] or Proteobacteria [23] rela-
tive to healthy controls.
Since the majority of Proteobacteria represented genus
Escherichia among all patients with enteric infections re-
gardless of the bacterial pathogen causing the infection, it is
likely that this microbial population is more frequently se-
lected for during an acute enteric infection. Factors that
contribute to an increase in specific microbes over others,
however, are not fully understood, though we do know that
microbiota depletion and host immune responses are likely
to be critical. Salmonella typhimurium, for instance, was
shown to outcompete the host microbiota by exploiting
host inflammatory immune responses [24] and utiliz-
ing luminal thiosulfate from the reactive oxygen spe-
cies generated during inflammation [25]. Similarly,
enterohemorrhagic E. coli and enteropathogenic E. coli
were shown to accept nitrate produced by host innate
immune cells for use as energy via anaerobic respiration
to enhance survival in the inflamed mouse intestine [26].
Because members of Bacteroidetes and Firmicutes cannot
utilize nitrate, it was suggested that the microbial balance
becomes disrupted by promoting overgrowth of both
pathogenic and commensal E. coli following inflammation
[26]. Our study provides additional support for these
findings and suggests that infection with not only
Fig. 4 Principle coordinate analysis depicting the shift in microbial
communities following recovery. Intestinal communities of 13 patients
with a Campylobacter (n = 3), b Salmonella (n = 6), and c Shigella (n = 4)
infections were compared during the acute enteric infection (red) and
post-recovery (green). A comparison was also made to the intestinal
communities among healthy family members (pink). The number of
individuals sampled during the acute infection stage did not always
equal the number of samples received following recovery due to
missing samples or loss to follow-up; hence, the time points were
pooled for the analysis
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pathogenic E. coli induces an increase in Escherichia levels
within infected intestinal communities. Increases were
also observed in patients infected with Campylobacter,
Salmonella and Shigella. Interestingly, STEC patients had
the highest levels of Escherichia as compared to patients
with Campylobacter, Shigella, and Salmonella infections,
suggesting that both the pathogenic STEC and commensal
Escherichia population were selected for at the time of the
infection. In addition, the decrease in Proteobacteria levels
among the 13 patients following recovery from infection
demonstrates that the increase in Proteobacteria levels oc-
curred during the acute infection and that healthy levels are
significantly lower. A study of Cholera reported similar
findings as Proteobacteria was more abundant during
the acute stage of Cholera infections in nine children
when compared to 28 days post-infection [27].
In addition to the decreasing level of Proteobacteria
belonging to genus Escherichia identified in a subset of
patients post-infection, we also observed significant in-
creases in phyla Firmicutes and Bacteroidetes, which
were not significantly different from levels in healthy
family members. These results are consistent with prior
reports demonstrating that intestinal communities
recover following perturbations. Several studies, for in-
stance, have documented a shift in intestinal communi-
ties during periods of antibiotic use with recovery of
those communities occurring soon after antibiotic cessa-
tion [17, 18]. Other studies have also shown that disrup-
tions in intestinal microbial communities can result in
enhanced susceptibility to pathogen colonization, inva-
sion, and infection [15]. Future studies, however, are
needed to determine whether certain communities are
more susceptible to severe perturbation than others.
Here, we observed greater increases in Proteobacteria
and Escherichia levels in some patients and not others,
though logistic regression analyses did not link either
high Proteobacteria or Escherichia abundance with clin-
ical symptoms. Conversely, we found that patients with
intestinal community profiles belonging to clusters I/II
were significantly more likely to report a history of
bloody diarrhea than patients with distinct communities.
These patients were also significantly more likely to be
male, suggesting that the complete microbiota profile of
the cluster I/II communities are more important for dic-
tating disease outcomes during an acute infection than
the increased level of Escherichia. Because our sequen-
cing analyses focused on 16S rRNA genes, a more com-
prehensive metagenomic analysis is warranted between
these patient and family member communities to better
define which microbes comprise clusters I/II and III–V,
and identify relationships between complete microbiome
profiles and disease severity.
Collectively, the data presented herein demonstrate
that intestinal microbial communities become affected
in a similar way among patients with enteric infections
regardless of the pathogen type and age of the patient.
Perturbations of specific communities (e.g., Cluster I/II)
that are characterized by an increase in Escherichia are
more likely to have more severe symptoms; hence, it is pos-
sible that these communities with a higher abundance of
Escherichia take longer to recover to a healthy state. Future
studies should therefore focus on characterizing the popu-
lation of Escherichia as it is not clear whether there is over-
growth of one strain type or if the population is diverse
consisting of genetically distinct strains. Based on our data,
it is also important to consider future treatment strategies
that involve the use of probiotics or therapeutics that aim
to increase the abundance of beneficial microbes compris-
ing Bacteroidetes and Firmicutes and more rapidly decrease
Proteobacteria populations. Such strategies could poten-
tially decrease the burden of enteric infections and facilitate
a quicker recovery.
Conclusions
Enhancing our understanding of how intestinal micro-
bial communities change during an enteric infection and
identifying factors that influence these changes are im-
portant for the development of novel prevention and
treatment strategies. In our analysis of 200 intestinal
communities from patients and 75 healthy family mem-
bers, we found that specific intestinal microbiota are
more common among patients during an acute enteric
infection regardless of the type of enteric pathogen. Spe-
cifically, the intestinal microbial communities from patients
were more frequently dominated by Proteobacteria and not
Bacteroidetes and Firmicutes, which represent dominant
commensals and the most common phyla in human intes-
tinal communities. Patients with similar microbiota profiles
were more likely to have severe disease outcomes, suggest-
ing that increases in specific microbe populations, which
were primarily attributable to Escherichia, occur during an
infection. This finding is supported by the result that pa-
tient intestinal communities recovered over time to mimic
those communities of healthy family members, which were
classified by an increase in phyla Bacteroidetes and Firmi-
cutes and decrease in Proteobacteria belonging to genus
Escherichia. Future enteric disease prevention strategies
could therefore aim to decrease intestinal Escherichia levels
at the time of an acute infection while simultaneously
boosting microbes including Bacteroidetes that are most
important for restoring intestinal health.
Methods
Study design
An active surveillance system was created through the
MDHHS Bureau of Laboratories to identify 200 patients
infected with Campylobacter, Salmonella, Shigella, and
STEC at four participating Michigan hospitals.
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Surveillance began on January 1, 2011. Stools from each
patient were added to Cary-Blair transport media and
submitted to the MDHHS for de-identification, culture,
and transport to MSU for community DNA isolation
and 16S rRNA sequencing. Family members of patients
(n = 75) were enrolled by phone and asked to submit a
stool specimen preserved in Cary-Blair transport media
and to complete a questionnaire containing demo-
graphic information, exposures (e.g., animal contacts,
travel history), and signs of illness including duration,
type, and severity of clinical symptoms. Such informa-
tion was also available for each patient through the
Michigan Disease Surveillance Network (MDSS) main-
tained by the MDHHS Bureau of Epidemiology. A sub-
set of 13 patients was also re-contacted post-infection
for stool submission and questionnaire completion. Each
participant was required to provide informed consent
prior to enrollment and was given a monetary incentive
after samples were received at MDHHS. All protocols
were approved by the Institutional Review Boards at
MSU (IRB# 10-736SM), the MDHHS (842-PHALAB),
and each of the four participating hospitals (RR#12170,
University of Michigan; 202749-6 Sparrow Health Sys-
tem; 2011-039 Spectrum Health, and 022111MP4E,
Wayne State University/Detroit Medical Center).
DNA isolation and sample preparation
Stool samples were processed soon after receipt by both
MDHHS and MSU and time period from collection to
processing was noted. Following homogenization and
centrifugation, aliquots of stool were stored in triplicate
at −80 °C until further use. A total of 310 stools were ex-
amined in this analysis, which represent 41.8 % of the
total number of stools (n = 741) received via the ERIN
surveillance system through May 7, 2011. Stool DNA re-
covery (260/280 nm) and yield (ng/μl) were initially
compared using the QIAamp DNA Stool Mini Kit (QIA-
GEN; Valencia, CA) and the MoBio Fecal Isolation Kit
(MoBio; Carlsbad, CA) and standardized using the
NanoDrop (Thermo Fischer Scientific). Four stools were
compared using the manufacturer’s instructions, except
for the addition of a denaturation step (95 °C) followed
by bead beating for the QIAamp kit to enhance DNA
isolation of gram-positive bacteria as described [21].
Samples were also evaluated for changes before and after
homogenization. Overall, the QIAamp kit resulted in
better quality yields, enhanced diversity (Additional file
3: Figure S10), and better recovery of phyla representing
gram-positive bacteria (Additional file 3: Figure S11).
Hence, the QIAmp protocol was used for the remaining
306 samples. No differences were observed between
communities from the same individual before and after
homogenization.
Because all stool samples were transported in Cary-
Blair media to preserve the pathogens for culture, we
wanted to ensure that the preservation media did not
alter the composition of the microbiota (Additional file 3:
Figure S9). To do this, we incubated cattle feces obtained
through a different study with and without Cary-Blair
at 4 °C for up to 4 days; we did not have access to
unpreserved human samples. Four days represented
the average length of time for human samples to reach
our laboratory from the MDHHS prior to isolating
community DNA. Pyrosequencing was performed on
both sets of samples for comparison.
Pyrosequencing and community analysis
Isolated community DNA was amplified for the 16S
rRNA gene spanning the V5–V3 regions using universal
primers 357F and 926R tagged with the 454 universal
primers A and B at either end with barcodes for multi-
plexing samples. PCR amplification was performed using
AccuPrime™ Taq DNA polymerase (Invitrogen™) in tripli-
cate with initial denaturation at 95 °C for 2 min followed
by 30 cycles of 95 °C for 20 s, 50 °C for 30 s, and 72 °C
for 5 min. An amplicon library of 48 communities were
prepared for each sequencing run on 454 GS Junior Titan-
ium chemistry, by individually purifying the product using
the Agencourt AMPure XP (Beckman Coulter, Inc.) beads,
quanitification by pico green assays (Quant-iT™ PicoGreen®
dsDNA quanititation kit, Invitrogen™) followed by
normalization and pooling.
Sequencing analysis
Over 1 million reads were processed in the Quantitative
Insights Into Microbial Ecology (QIIME) software [28]
and aligned and classified using the Greengenes 16S
rRNA gene reference database. Sequence data were sub-
jected to quality trimming, filtering, and noise reduction
by QIIME denoiser using the default parameters [28].
The unaligned sequences were eliminated followed by
chimeric sequences and singleton removal using the
USEARCH quality filtering included in QIIME and the data
have been analyzed for microbial community composition,
diversity, and richness [29]. OTUs were clustered at 97 %
similarity cutoff using USEARCH where 16S rDNA se-
quences were classified using the Greengenes database.
Rarefaction curves were constructed using QIIME [28]
based on the observed OTUs in infected and uninfected
stool samples, Shannon diversity index, and the Chao1
richness estimator. The OTU biome table from QIIME
was used in Mothur to calculate richness and evenness
indices with 95 % confidence intervals (Additional file 1:
Tables S1 and Additional file 2: Table S2) as described pre-
viously [30]. LEfSe was then used to identify differentially
abundant microbial features as described previously [19].
UniFrac distances were calculated in QIIME for both
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abundance and composition and 3D principal coordinate
analysis plots were generated using KING (Kinemage,
Next Generation) [31].
Hierarchical clustering analysis and epidemiological
analyses
The phylogenetic data from QIIME was further analyzed
using Paleontological Statistics Software Package For Edu-
cation and Data Analysis (PAST) based on the NPMA-
NOVA and to calculate genera important for dissimilarities
between groups using SIMPER. Additional 2D principal co-
ordinate analysis plots based on both the Bray-Curtis and
Jaccard similarity coefficients were also constructed for a
weighted and unweighted analysis (28). Box plots were con-
structed using SigmaPlot 10.0.
Links to epidemiological data were made after clustering
relationships were identified between the stool communi-
ties based on abundance profile calculated by Bray-Curtis
dissimilarity index in PAST for generation of neighbor-
joining tree followed by tree construction in FigTree
(http://tree.bio.ed.ac.uk/software/figtree/). We tested for
differences in the frequency of clinical characteristics in-
cluding HUS, diarrhea, bloody diarrhea as well as for vari-
ous factors including age and gender, across the different
microbial community clusters using the likelihood chi-
square test or Mantel-Haenszel chi-square (for variables
with more than two outcomes) distributions using odds ra-
tios with 95 % confidence intervals performed with Statis-
tical Analysis Software (SAS) (version 9.3).
Availability of supporting data
Raw sequence data is available at (http://dx.doi.org/
10.6084/m9.figshare.1447256), while the metadata and
taxonomic classifications have been included as Additional
files 4 and 5.
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